1. Home
  2. WEAV vs ABUS Comparison

WEAV vs ABUS Comparison

Compare WEAV & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • ABUS
  • Stock Information
  • Founded
  • WEAV 2011
  • ABUS 2005
  • Country
  • WEAV United States
  • ABUS United States
  • Employees
  • WEAV N/A
  • ABUS N/A
  • Industry
  • WEAV EDP Services
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEAV Technology
  • ABUS Health Care
  • Exchange
  • WEAV Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • WEAV 650.3M
  • ABUS 611.0M
  • IPO Year
  • WEAV 2021
  • ABUS N/A
  • Fundamental
  • Price
  • WEAV $7.74
  • ABUS $3.22
  • Analyst Decision
  • WEAV Strong Buy
  • ABUS Strong Buy
  • Analyst Count
  • WEAV 5
  • ABUS 4
  • Target Price
  • WEAV $16.10
  • ABUS $5.50
  • AVG Volume (30 Days)
  • WEAV 1.0M
  • ABUS 774.3K
  • Earning Date
  • WEAV 07-31-2025
  • ABUS 08-04-2025
  • Dividend Yield
  • WEAV N/A
  • ABUS N/A
  • EPS Growth
  • WEAV N/A
  • ABUS N/A
  • EPS
  • WEAV N/A
  • ABUS N/A
  • Revenue
  • WEAV $212,950,000.00
  • ABUS $6,403,000.00
  • Revenue This Year
  • WEAV $18.69
  • ABUS $3.35
  • Revenue Next Year
  • WEAV $15.71
  • ABUS N/A
  • P/E Ratio
  • WEAV N/A
  • ABUS N/A
  • Revenue Growth
  • WEAV 19.58
  • ABUS N/A
  • 52 Week Low
  • WEAV $7.25
  • ABUS $2.71
  • 52 Week High
  • WEAV $17.63
  • ABUS $4.73
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 40.45
  • ABUS 48.90
  • Support Level
  • WEAV $7.25
  • ABUS $3.08
  • Resistance Level
  • WEAV $8.28
  • ABUS $3.30
  • Average True Range (ATR)
  • WEAV 0.33
  • ABUS 0.10
  • MACD
  • WEAV 0.05
  • ABUS 0.01
  • Stochastic Oscillator
  • WEAV 29.04
  • ABUS 50.00

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: